Schedule 13D ownership disclosure

IMAGENEBIO INC

Common Stock, $0.001 par value per share · CUSIP: 45175G207

Event date: 2025-07-25

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Atlas Venture Fund X, L.P.Reported CIK 0001628098

    Shares: 241,800.00 · Class: 2.1%

  • ATLAS VENTURE ASSOCIATES X, L.P.Reported CIK 0001742766

    Shares: 241,800.00 · Class: 2.1%

  • Atlas Venture Associates X, LLCReported CIK 0001742765

    Shares: 241,800.00 · Class: 2.1%

  • Atlas Venture Fund XI, L.P.Reported CIK 0001708269

    Shares: 103,494.00 · Class: 0.9%

  • Atlas Venture Associates XI, L.P.Reported CIK 0001780068

    Shares: 103,494.00 · Class: 0.9%

  • Atlas Venture Associates XI, LLCReported CIK 0001780067

    Shares: 103,494.00 · Class: 0.9%

  • Atlas Venture Opportunity Fund I, L.P.Reported CIK 0001759241

    Shares: 72,885.00 · Class: 0.6%

  • Atlas Venture Associates Opportunity I, L.P.Reported CIK 0001780065

    Shares: 72,885.00 · Class: 0.6%

  • Atlas Venture Associates Opportunity I, LLCReported CIK 0001780066

    Shares: 72,885.00 · Class: 0.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-020462
Form type
SCHEDULE 13D/A
Filer
Atlas Venture Fund X, L.P.
CIK
CIK 1628098
Filed
Jul 29, 2025
Reporting period
Jul 25, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub